Baseline CD8 lymph node avidity with 89-Zr-crefmirlimab in patients with metastatic renal cell carcinoma and response to IO therapy Meeting Abstract
| Authors: | Zang, P. D.; Twardowski, P.; Chen, D. L.; Hall, E. T.; Hays, D.; Wilson, I.; Schmiedehausen, K.; Ferris, M.; Le, W.; Postow, M. A.; Pal, S. K. |
| Abstract Title: | Baseline CD8 lymph node avidity with 89-Zr-crefmirlimab in patients with metastatic renal cell carcinoma and response to IO therapy |
| Meeting Title: | 2024 ASCO Genitourinary Cancers Symposium |
| Keywords: | 38092-20125 |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2024 Jan 25-27 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-02-01 |
| Language: | English |
| ACCESSION: | WOS:001266676900229 |
| DOI: | 10.1200/JCO.2024.42.4_suppl.375 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 375 -- Source: Wos |
